Strategia terapeutica nella malattia avanzata Claudia Bighin Istituto Nazionale per la Ricerca sul Cancro Genova Roma, 19 Febbraio 2005.
St. Gallen March 11-14, 2009 Roma 11 Giugno 2009 Teresa Gamucci Oncologia Medica Sora (FR)
Phase II study of Erbitux, CisPlatin, Epirubicin, Leucovorin with UFT (E-PELUF) as neoadjuvant treatment in patients with gastric cancer Dr Efraim Idelevich.
MODELS OF SYSTEMIC TREATMENT IN BREAST CANCER EMRA against cancer 1 st Forum NGOs and cancer: Challenges and opportunities NGOs and cancer: Challenges.
Richard F. Kucera, M.D., and David West, M.D. Pulmonary and Critical Care Associates, Greensburg, Pennsylvania INTRODUCTION CASE PRESENTATION DISCUSSION.
Soirée AERIO 23 novembre 2011 Joseph GLIGOROV APHP Tenon.
Pancreatic cancer perspectives Is there any improvement ? Pancreatic cancer perspectives Is there any improvement ?
1 GCT9701 Please see Brief Summary and accompanying full Prescribing Information on slides 29-32. Indications may vary between countries. This piece is.
Circulating Tumor Cells and Their Prognostic and Predictive Value in Breast Cancer Massimo Cristofanilli, M.D., F.A.C.P. Professor and Chairman Medical.
Semuloparin for Trial of Thrombophylaxis in Patients receiving Chemotherapy for Cancer Agnelli, G. George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti.
Allogreffes et hémopathies lymphoïdes G Salles ESH Tunis 29-31 Octobre 2010.
Mediterranean School of Oncology DIAGNOSTIC AND THERAPEUTIC BURNING QUESTIONS ON LYMPHOPROLIFERATIVE DISEASES Rieti 27-29 Ottobre 2006 DALLA CHEMIOTERAPIA.
